Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 12/20 | 0.40 |
| ▸ | LCK | P06239 | 8/20 | 0.39 |
| ▸ | KDR | P35968 | 8/20 | 0.39 |
| ▸ | TEK | Q02763 | 8/20 | 0.39 |
| ▸ | BLK | P51451 | 2/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.38 |
| ▸ | RET | P07949 | 1/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.38 |
| ▸ | FLT3 | P36888 | 1/20 | 0.38 |
| ▸ | TEC | P42680 | 1/20 | 0.38 |
| ▸ | TXK | P42681 | 1/20 | 0.38 |
| ▸ | BMX | P51813 | 1/20 | 0.38 |
| ▸ | ITK | Q08881 | 1/20 | 0.38 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26108112 | 0.87 | LCK (0.40) | BTKLCKKDRTEKBLK | |
| SCHEMBL30582500 | 0.83 | BTK (0.55) | BTKBLKEGFRERBB2RET | |
| SCHEMBL30582591 | 0.83 | LCK (0.42) | BTKLCKKDRTEKBLK | |
| SCHEMBL26108281 | 0.83 | LCK (0.42) | BTKLCKKDRTEKBLK | |
| SCHEMBL26108768 | 0.82 | BTK (0.36) | BTKLCKKDRTEKBLK | |
| SCHEMBL26105238 | 0.81 | SRC (0.43) | BTKLCKKDRTEKEGFR | |
| SCHEMBL30582582 | 0.81 | SRC (0.43) | BTKLCKKDRTEKEGFR | |
| SCHEMBL26107761 | 0.79 | BTK (0.35) | BTKLCKKDRTEKBLK | |
| SCHEMBL26587238 | 0.77 | LCK (0.49) | BTKLCKKDRTEKEGFR | |
| SCHEMBL26109060 | 0.76 | BTK (0.35) | BTKLCKKDRTEKBLK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023192502-A1 | SPIROBICYCLIC COMPOUNDS | ACERAND THERAPEUTICS (USA) LIMITED (US) | 2023-10-05 | — | — | WO | claimed |
| WO-2023192502-A1 | SPIROBICYCLIC COMPOUNDS | ACERAND THERAPEUTICS (USA) LIMITED (US) | 2023-10-05 | — | — | WO | disclosed |